AFP	Alpha-fetoprotein
cfDNA	Cell-free DNA (cfDNA)
CNVs	Copy number variations
CR	Complete response
ctDNA	Circulating tumoral DNA
CTLA4	Cytotoxic T-Lymphocyte Antigen 4
GGT	Gamma-glutamyl transferase
HCC	Hepatocellular carcinoma
ICIs	Immune checkpoint inhibitors
irAEs	Immune-related adverse events
mRECIST	Modified Response Evaluation Criteria in Solid Tumors
ORR	Objective radiological response
PD	Progressive disease
PD-L1	Programmed cell Death-ligand 1
PFS	Progression-free survival
PR	Partial response
TMB	Tumor mutational burden
SD	Stable disease
OS	Overall survival